Abstract

The benefits (in terms of cost reduction and DALYs averted) of enhancing prevention and early diagnosis procedures for cervical, colorectal, and breast cancer in low- and middle-income countries (LMICs) are estimated. The study defines a focus person as someone who can develop cancer during his/her life. In each case, a “standard medical protocol” is established to determine the procedures used to screen, early diagnose, and treat the disease. The epidemiological model for each type of cancer is established based on its natural history and on its probability of developing during the person’s life. Each model establishes the relevant medical procedure associated with the development of the disease. The expected cost for each disease is obtained by linking this information with cost data for each procedure. DALYs are determined using the health state valuations reported by the GBD 2004 Update (WHO, 2008). Regional-level estimates are then obtained for each WHO region. Results show that total expected costs from cervical, colorectal, and breast cancer drop significantly as a result of strengthening prevention and early diagnosis. In the case of cervical cancer, the reduction in total costs created by moving from the non-preventive to the preventive scenario ranges from US$ 3.1 billion in region AMRO D to US$ 55.0 billion in region WPRO B. In the case of colorectal cancer, the total cost reduction ranges from US$ 1.3 billion in region AMRO D to US$ 37.0 billion in region WPRO B. Finally, in the case of breast cancer, the total cost reduction ranges from US$ 12 billion in region EMRO D to US$ 365 billion in region WPRO B. The paper also estimates a production possibility frontier for each cancer type, providing a comparison between expected cancer-associated medical costs for preventive scenarios and its economic benefits with an aim to illustrate the locations where public policy focusing on prevention and early diagnosis would have the highest outcomes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.